1. The first problem is that the role of podiatrist is multifactorial, covering screening for risk, management of increased risk, regular surveillance and treatment of active disease, rapid referral to other experts, as well as education of both users and professionals. Most of the published work (including a lot that is reviewed here) relates to patient education and hence the only conclusions that can be drawn from this work relate to the educational activity. In this respect this review adds nothing to the Cochrane reviews by Dorresteijn (apart from including studies that aren't RCTs). On the other hand, it excludes some papers on education because podiatrists were not specifically involved). To search only for interventions performed by a single professional group reveals limited insight into the importance of team working in this clinical area. 2. The second problem is the fact that the training and clinical responsibilities of podiatrists are enormously different in different countries (unrelated to whether they are called podiatrists or chiropodists). Most diabetic foot care in the US is, for example, led by podiatrists who are medically and surgically trained and will undertake many of the operations that are required below the knee, including BKA, and they are also prescribers. In UK and many other countries, the majority of podiatrists are not so highly qualified and they have different roles and more often work in MDTs. Teamworking may be to the patient's advantage because it is known that the incidence of major amputation in UK is currently about half that in the USA: about 1 per 1000 ppy, versus 2+ (probably). Because there are different types of podiatrist, it is illogical to lump both together. 3. The third problem is that this analysis isas, indeed, is much of the US literaturebased on the use of the term LEA (lower extremity amputation: minor and major amputations combined). LEA is a poor marker of effectiveness of care, and this has been extensively debated in the published literature. The first reason is that amputation is a treatment and not necessarily a robust marker of disease severity or progression. It makes as much sense to count amputations as it does to count operations in the management of malignancies, colectomies or mastectomies for example. The second problem is that the incidence of amputation for foot disease is dependent on many different stages of clinical care, taking place over many years: glycaemic control, smoking cessation, screening, education and appropriate early management of new ulceration by all the many health care professionals who may be involved. In such circumstances it can be difficult to demonstrate the benefit of one particular professional group. The third reason is the fact that minor and major amputations are done for different reasons (either to save a leg or to remove one that cannot be saved, and in different patient groups: those with better and worse circulation, respectively; those with differing survival expectations in some cases). It is for these reasons that it makes no sense to combine them as a single outcome measure for diabetic foot disease. 4. The fourth problem is that the involvement of a podiatrist may actually reflect the fact that their input is required: ie they see the people who are at greater risk. This will confound cohort studies. The involvement of podiatrists may also sometimes lead to an increase in the number of minor amputations. This is seen in the US, in particular, because of the still widely-held belief that bone infection should properly be treated by bone excisionand this does not reflect usual practice in other countries, including the UK. 5. There is one important reference missing: RCT reported by McMurray SD (in 2002 or 2003) on the introduction of podiatry into dialysis unitsprobably the best evidence that there is a chance that this professional group may have a beneficial effect on outsome.
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GENERAL COMMENTS
This is a nice meta-analysis. It should be published. It is a nice example of how committees make decisions about methods of care not based on evidence. While it makes sense that comprehensive care including podiatrist care should be beneficial the proper studies have not been done. There are likely many reasons that your study is negative and may be related to the heterogeneity you describe as well as issue of selection bias this does not diminish the need to publish your study.
Your manuscript needs to be edited for style and grammar. You also need to be careful with some of your terms. For example randomization does not assure the elimination of bias and confounding. It is certainly a gold standard technique to minimize these biases. It is also important to remember that heterogeneity is not always bad and my be informative with respect to generalizability a topic often overlooked in homogeneous meta-analyses. Abstract BACKGROUND: We sought to examine the economic value of specialized lower-extremity medical care by podiatric physicians in the treatment of diabetic foot ulcers by evaluating cost outcomes for patients with diabetic foot ulcer who did and did not receive care from a podiatric physician in the year before the onset of a foot ulcer. We share the opinion of this reviewer that the role of a podiatrist is multifactorial. In addition to providing formal education, the majority of podiatrists will informally deliver education as part of their treatment of clinical conditions. Thus, we decided 'attending a podiatrist for treatment alone or for treatment and education' is an intervention worthy of review. We consider this review to build on the two previous Cochrane reviews on this topic by highlighting an area where further research is needed [1, 2] . To the best of our knowledge, research is underway to evaluate the effectiveness of podiatry services as part of the 'Putting Feet First' Campaign in the National Health Service (NHS), UK. We agree however, that this review has limited implication to current clinical practice. We state in the discussion that 'this review cannot make any recommendations about practice'.
REVIEWER

METHODS
We recognise the importance of the role of the multidisciplinary team in the clinical setting. In the discussion, we mention that 'looking at one service in isolation could be flawed as services are seldom delivered in isolation'. However, ideally evidence should exist that all members of a multidisciplinary team are effective and that together, the overall effectiveness is improved. It would be preferable for policy-makers to base decisions and fund investment in podiatry services on sound evidence. Thus, we consider this review looking at contact with one member of the team, the podiatrist, valid but we do suggest in the discussion that 'a systematic review of the literature looking at the effectiveness of multidisciplinary teams which include contact with a podiatrist would be useful'.
2. We acknowledge that the varying training and clinical responsibilities of podiatrists in different countries is a concern. However, notwithstanding these differences, podiatrists treat foot disease in all countries. Thus, we consider the intervention in this review valid.
3. The use of the term Lower Extremity Amputation (LEA) has indeed been extensively debated in the published literature. It is becoming more widely recognised that an early minor amputation can be prevent a later major amputation [3] . Thus, minor amputations may reflect improved quality of care with earlier intervention; consequently preventing the progression from minor to major amputation [4] .
As clinical practice changes, the distinction between major and minor LEAs are more commonly being described in the literature [5] [6] . This is preferable [7] . However, as we did not impose time limits on our search, it would be unwise to limit the search to major LEAs only. Furthermore, two previous Cochrane reviews by Dorresteijn et al studied the outcome of LEA in patients with diabetes and included papers with partial or total amputation rates [1] [2].
4. We acknowledge that involvement of a podiatrist may actually reflect the fact their input is required. Recent guidelines from Scotland outline a diabetic risk stratification and triage tool, highlighting which people need podiatry referral [8] . According to these guidelines, all patients classified as moderate risk (i.e. at least one risk factor present), severe risk or with active disease require podiatry review. For each study included in this review, risk of foot disease at baseline was assessed using this Diabetic foot risk stratification and triage system. As mentioned in the discussion section of the manuscript, ''A priori' sensitivity analyses were planned for different levels of baseline risk but there were insufficient data'.
5.
Many thanks for your suggestion that we should include the RCT by McMurray SD et al. [9] . In our protocol, we outlined that the intervention under review was 'attending a podiatrist for treatment alone or for treatment and education'. In the Reviewer #2: David J Margolis Many thanks for the positive feedback. As this reviewer correctly highlighted, randomisation is the gold standard technique to minimize bias but it does not eliminate bias and confounding. The manuscript has been amended to clarify this point and has been edited for style and grammar.
Reviewer #3: John Steinberg
We agree that the source data is weak and inconclusive and we hope that this review will encourage further research in this area. We thank the reviewer for the suggestion of a potential paper for inclusion [10] . This paper looks at the outcome of diabetic foot ulcers and thus, does not comply with the inclusion criteria in the protocol where an outcome of lower extremity amputation was specified.
Reviewer #4: Tim Pickles Results:
As the reviewer correctly assumed, we chose the fixed effects model for RCTs because of the low Q value (Q=0.328, p=0.567). Both fixed and random effects models produced the same result; RR of 1.41 (95% CI 0.20-9.78). As the reviewer suggested, we did consider not doing a meta-analysis for RCTs as only two suitable studies exist. However, for the sake of consistency, we decided to present both meta-analyses for randomised and non-randomised studies.
In relation to the non-randomised studies, the criterion to use the fixed model was not met so the random effects model was the more appropriate choice.
There is much debate on the appropriateness of combining the results of randomised and nonrandomised studies in a single meta-analysis. Initially, we performed meta-analyses of the RCTs and cohort studies both in combination and separately. However, we excluded the combined analysis from this paper based on expert statistical advice received after presenting those findings at a Cochrane Collaboration Conference in Dublin City University, Ireland (January 2012). Also, expert guidelines on the reporting of meta-analysis of RCTs and observational studies exist individually but not in combination [11] [12] . We have used the PRISMA Checklist here to report the results of both metaanalyses.
Discussion: 'A priori' sensitivity analyses as per study design and as per baseline foot risk were planned. As mentioned in the protocol, 'The search will include case-control studies, cohort studies, retrospective and prospective studies, articles, clinical trials and RCTs' and 'Risk of foot disease at baseline will be assessed using the Diabetic foot risk stratification and triage system from the SIGN (Scottish Intercollegiate Guidelines Network) guidelines'. Apologies for not outlining in the protocol that we planned to perform analyses as per study design and as per baseline foot risk. PRISMA Checklist:
The reviewer correctly pointed out that objectives were not explicitly outlined on page 4. We have amended the manuscript to include in the introduction an explicit statement of the question being addressed with reference to participants, intervention and outcome.
We mention in the methods that 'The research question, inclusion and exclusion criteria and proposed methods of analysis were specified in advance and documented in a protocol (attached as supplementary file)'. Our understanding is that the supplementary file containing the protocol would be accessible online to the reader.
The additional analysis that we refer to in the PRISMA Checklist is the sensitivity analysis as per baseline foot risk we had planned. As the reviewer correctly pointed out, results of the additional analysis was not presented as insufficient data existed to facilitate performance of the sensitivity analysis. We have now amended the PRISMA Checklist accordingly.
